| Fri, Nov 27, 2009 | | • | MorphoSys to Present at 21st Piper Jaffray Healthcare Conference
Marketwire (Fri, Nov 27)
| | Tue, Nov 24, 2009 | | • | Dr. Simon Moroney Awarded Bavarian State Medal for Outstanding Services to the Bavarian Economy
Marketwire (Tue, Nov 24)
| | Mon, Nov 9, 2009 | | • | MorphoSys Receives Regulatory Approval to Start Phase 1b/2a Clinical Trial for MOR103 Program
Marketwire (Mon, Nov 9)
| | Wed, Nov 4, 2009 | | • | MorphoSys to Present at Two Upcoming Investor Conferences
Marketwire (Wed, Nov 4)
| | Wed, Oct 28, 2009 | | • | MorphoSys AG Reports Results for the First Nine Months of 2009
Marketwire (Wed, Oct 28)
| | Thu, Oct 22, 2009 | | • | MorphoSys to Host Q3 2009 Conference Call on October 28, 2009
Marketwire (Thu, Oct 22)
| | Tue, Oct 20, 2009 | | • | MorphoSys and Daiichi Sankyo Forge Alliance to Develop Novel Antibody Therapies against Hospital-Acquired Infections
Marketwire (Tue, Oct 20)
| | Wed, Sep 16, 2009 | | • | MorphoSys Appoints Head of Clinical Development
Marketwire (Wed, Sep 16)
| | Mon, Sep 14, 2009 | | • | AbD Serotec and FIND Sign Agreement to Develop Temperature Stable Antibodies for In Vitro Diagnostics
Marketwire (Mon, Sep 14)
| | Tue, Sep 8, 2009 | | • | MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma
Marketwire (Tue, Sep 8)
| | Fri, Aug 28, 2009 | | • | MorphoSys to Present at Six Upcoming Investor Conferences
Marketwire (Fri, Aug 28)
| | Wed, Jul 29, 2009 | | • | MorphoSys AG Reports Six Months 2009 Results
Marketwire (Wed, Jul 29)
| | Thu, Jul 23, 2009 | | • | MorphoSys to Host Q2 2009 Conference Call on July 29, 2009
Marketwire (Thu, Jul 23)
| | Thu, Jul 9, 2009 | | • | MorphoSys AG: AbD Serotec and Spinreact Sign Supply Agreement for Antibodies Used in Clinical Diagnostic Kits
Marketwire (Thu, Jul 9)
| | Mon, Jul 6, 2009 | | • | MorphoSys Secures Full-Term of Strategic Alliance
Marketwire (Mon, Jul 6)
| | Thu, Jul 2, 2009 | | • | MorphoSys and the University of Melbourne File New Patent Applications in MOR103 Program
Marketwire (Thu, Jul 2)
| | Mon, Jun 29, 2009 | | • | MorphoSys Announces Clinical Milestone in Therapeutic Antibody Program
Marketwire (Mon, Jun 29)
| | Wed, Jun 24, 2009 | | • | MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead Program MOR103 in Rheumatoid Arthritis
Marketwire (Wed, Jun 24)
| | Thu, Jun 18, 2009 | | • | MorphoSys Strengthens Patent Position on its Core Technologies in Japan
Marketwire (Thu, Jun 18)
| | Tue, Jun 16, 2009 | | • | MorphoSys Announces Extension of Antibody Alliance with Schering-Plough
Marketwire (Tue, Jun 16)
|
Add MOR.F News to My Yahoo!:
 
| |
|
0.18% Nasdaq 
0.42%
Headlines
